Position in RYTM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$198,268,046
+$86,398,275 QoQ
Shares Held
1,785,716
+38.8% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#13
of 299 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. RYTM ranks #2 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in RYTM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $198,268,046 | 1,785,716 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $111,869,771 | 1,286,303 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $173,815,939 | 1,623,841 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $174,499,105 | 1,727,885 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $106,569,554 | 1,686,494 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $84,321,405 | 1,591,871 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $86,748,566 | 1,549,635 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $87,171,721 | 1,663,900 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $68,191,790 | 1,660,784 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $71,975,333 | 1,661,097 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $106,234,600 | 2,310,955 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $53,675,104 | 2,341,335 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $64,173,852 | 3,891,683 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $69,427,624 | 3,891,683 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $183,586,515 | 6,304,482 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $154,518,217 | 6,306,866 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,241,740 | 4,395,600 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $58,350,101 | 5,065,113 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,977,283 | 2,803,335 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $39,324,352 | 3,011,053 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $59,037,831 | 3,015,211 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $66,167,843 | 3,110,853 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $77,821,248 | 2,617,600 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $49,138,892 | 2,267,600 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $50,533,383 | 2,266,071 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $34,486,998 | 2,265,900 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||